by John A. Jenkins | May 20, 2026 | FOIA, NASA
FOIA Requests From Former CIA, FBI agents Across the United States, cybersecurity teams at federal agencies, defense contractors, telecom firms, and critical infrastructure operators are being warned to prepare for the next Russian cyberattack. In March, the Federal...
by John A. Jenkins | May 14, 2026 | FOIA, Litigation, Pharmaceuticals, SEC
FOIAengine: Requests to SEC Preceded Stock Troubles and a Surprise Resignation For a company that most Americans have never heard of, Medpace Holdings, Inc. (NASD:MEDP) sits remarkably close to the center of the modern drug-development economy. The Cincinnati-based...
by Randy Miller | May 6, 2026 | FDA, FOIA, Hedge Funds, Pharmaceuticals, Short-Selling, Stock Market
FOIAengine: Assessments Include Operational, Clinical and Commercial Threats Freedom of Information Act requests to the Food and Drug Administration during March illustrated three of the primary uncertainties facing U.S. drug manufacturers and their investors: the...
by Randy Miller | Apr 22, 2026 | EPA, FOIA, News Media, Politics
FOIAengine: Journalists Seek EPA Communications on Iran Bombing A small circle of reporters – concentrated overwhelming at one news organization – is using the Freedom of Information Act to run what amounts to a systematic, real-time audit of Environmental Protection...
by John A. Jenkins | Apr 9, 2026 | FDA, FOIA, Litigation, Medical Devices, Short-Selling, Stock Market
How FOIA Requests Signaled Problems With a “Bionic Pancreas” At a federal advisory panel meeting in 2018, a biomedical engineer named Ed Damiano stepped to the microphone – not just as a scientist. “I’m also a father,” he told regulators, describing his son’s...
by John A. Jenkins | Apr 1, 2026 | FDA, FOIA
FOIAengine: Advocates on Both Sides Push FDA for Data as a Senate Investigation Begins Even before Sen. Josh Hawley (R-Mo.) walked into a March 11 news conference to kick off an effort to ban the abortion drug mifepristone as unsafe – and days before he opened an...
